506
Participants
Start Date
January 30, 2023
Primary Completion Date
December 9, 2024
Study Completion Date
June 30, 2026
unfractionated heparin
intranasal
0.9%sodium chloride
intranasal
The Northern Hospital, Epping
Lead Sponsor
University of Melbourne
OTHER
Northern Hospital, Australia
OTHER
Monash University
OTHER
The Peter Doherty Institute for Infection and Immunity
OTHER
St Vincent's Hospital Melbourne
OTHER
Murdoch Childrens Research Institute
OTHER